Diabetic drug metformin found to act on brain
NEW DELHI: Cheap, effective and widely trusted, metformin has long been the first choice for treating type 2 diabetes. Now, scientists say the drug works in a way few had…
Hetero debuts semaglutide generic in emerging markets
New Delhi: Hyderabad-based drugmaker Hetero has announced the launch of its generic semaglutide portfolio in emerging international markets. In a phased global push, the company plans to roll out its…
LB Pharma Begins Pivotal Phase 3 Schizophrenia Trial
Phase 2 results for LB-102 showed statistically significant reductions in PANSS total score across all doses with onset by week 1 and sustained through study end, alongside low rates of…
Check manufacturing, sale of 26 unapproved drugs, central regulator tells state authority
After substandard drug manufacturing, the state drug firms are once again under the scanner of the central government for manufacture and sale of unapproved fixed dose combination (FDC) drugs which…
Stem cell therapy for autism illegal: NMC advisory
New Delhi: The National Medical Commission (NMC) issued a strict advisory on March 25, 2026, declaring stem cell therapy illegal for treating Autism Spectrum Disorder and cerebral palsy in routine…
India’s Essential Medicines Prices To Increase Marginally From 1 April Under Annual Pricing Framework
Prices of nearly 900 essential medicines, including painkillers and antibiotics, are set to rise by around 0.65 per cent starting 1 April following a directive from India’s drug pricing regulator.…
Delhi HC Asks Dr Reddy’s To Halt Olymviq Sales; Flags Similarity With Novo Nordisk’s Ozempic
The court also asked Dr Reddy’s to inform it by Friday whether it is willing to drop the “Olymviq” brand name, as the matter centres around alleged trademark similarity with…
NPPA allows 0.64% hike in MRP of essential drugs in line with WPI rise
New Delhi: The National Pharmaceutical Pricing Authority (NPPA) on Wednesday announced that manufacturers may increase prices of scheduled formulations included in the National List of Essential Medicines (NLEM) by 0.64…
Govt Outlines AYUSH Heavy Metal Monitoring Steps In Rajya Sabha
New Delhi: The Ministry of AYUSH has detailed its regulatory framework and ongoing initiatives to monitor heavy metal content in traditional medicines, responding to parliamentary concerns over quality and safety…
Regulation Of Hair Transplant And Cosmetic Clinics Under The Purview Of States, No Plans To Create A Central Database Or Registry: Govt In RS
New Delhi: The Union Government has clarified that the regulation, licensing, and oversight of hair transplant and cosmetic surgery clinics remain primarily the responsibility of State Governments and Union Territories,…
